Novel antibiotics excel for hospital infections and offer long action.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002435:Cefamandole / Q000031:analogs & derivatives / Q000627:therapeutic use; D002511:Cephalosporins; D002513:Cephamycins / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D014481:United States